Opportunities Preloader

Please Wait.....

Report

United States Women's Health Market By Drug (ACTONEL, YAZ, Yasmin, Yasminelle, FORTEO, Minastrin 24 Fe, Mirena, NuvaRing, ORTHO TRI-CY LO, Premarin, Prolia, Reclast/Aclasta, XGEVA, Zometa, Others), By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region and Competition, Opportunity, and Forecast, 2019-2029F

Market Report I 2024-05-15 I 90 Pages I TechSci Research

United States Women's Health Market was valued at USD 19.78 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.39% through 2029. The United States Women's Health Market is a multifaceted and evolving sector of the healthcare industry that focuses on addressing the unique health needs and concerns of women. It encompasses a wide range of medical, pharmaceutical, and wellness services designed to promote and maintain the well-being of women throughout their lives. From reproductive health to menopause, from breast cancer screenings to mental health support, the United States Women's Health Market plays a crucial role in enhancing the overall quality of life for women across the nation. One of the key areas of focus within this market is reproductive health. This includes family planning, prenatal care, and support for pregnancy and childbirth. The availability of contraception options, fertility treatments, and comprehensive maternity care is vital for women's choices and overall health.
Gynecological services, which include regular check-ups, cancer screenings, and treatment for conditions like endometriosis and polycystic ovarian syndrome, are essential components of women's healthcare in the United States. Breast health is another significant aspect of women's health in the U.S., with a strong emphasis on early detection and prevention of breast cancer. Mammography and breast self-examinations, along with advanced treatment options, contribute to increased survival rates and improved outcomes for those affected by this prevalent disease. Mental health is an integral part of women's well-being, and the United States Women's Health Market recognizes the importance of addressing issues such as postpartum depression, anxiety, and eating disorders. The market offers various therapeutic and counseling services to support women's emotional and psychological health. Moreover, as women age, the market provides specialized care and resources for the challenges that come with menopause, osteoporosis, and other age-related conditions. This comprehensive approach to women's health extends to holistic wellness, with an increasing focus on lifestyle factors, nutrition, fitness, and wellness programs aimed at improving overall quality of life.
Key Market Drivers
Demographic Shifts and Aging Population
Demographic shifts and the aging population in the United States are pivotal factors propelling the growth of the Women's Health Market. As the baby boomer generation reaches retirement age, a profound transformation is occurring in the healthcare sector, particularly in the realm of women's health. This demographic shift brings with it a substantial increase in the number of older women, who have distinct and evolving healthcare needs.
The aging population presents a higher demand for specialized healthcare services catering to older women. Conditions such as menopause, osteoporosis, cardiovascular diseases, and age-related cancers become more prevalent as women age. This necessitates a greater focus on preventive care, early detection, and management of these health issues. Healthcare providers are adapting their services and facilities to meet the unique requirements of this aging demographic, which includes tailored treatment plans, geriatric-focused care, and comprehensive wellness programs.
Women tend to live longer than men on average, and this longevity accentuates the importance of healthcare services that cater to their specific health needs. With the increased lifespan, women are seeking healthcare solutions that address both the challenges and opportunities that come with aging. These solutions may encompass hormone replacement therapy, bone density screenings, and nutritional guidance tailored to aging bodies.
The United States Women's Health Market is consequently evolving to meet these growing demands, providing a spectrum of healthcare services that empower older women to age gracefully and maintain their quality of life. This not only fosters well-being among the aging female population but also serves as a driving force behind the overall expansion of the Women's Health Market.
Rising Technological Advancements
Technological advancements are playing a pivotal role in boosting the United States Women's Health Market, revolutionizing the way healthcare is delivered and improving outcomes for women. These innovations encompass a wide range of medical technologies and practices that are reshaping the landscape of women's health.
One of the most significant advances is the development of cutting-edge diagnostic tools. Technologies such as 3D mammography and advanced imaging techniques have greatly enhanced the early detection and diagnosis of breast cancer, which is a top concern for women. These state-of-the-art imaging methods offer greater accuracy and sensitivity, leading to earlier intervention and improved survival rates.
In the field of gynecology and minimally invasive surgery, robotic-assisted surgery has become a game-changer. This technology allows for more precise and less invasive procedures for conditions like fibroids, endometriosis, and ovarian cysts. Women can now benefit from shorter recovery times, reduced scarring, and less post-operative pain, thanks to these technological advancements.
Telemedicine has also emerged as a critical component of women's healthcare. It provides convenient and accessible healthcare services, particularly for rural or underserved populations. Women can now consult with healthcare professionals, access follow-up care, and receive advice on a wide range of issues, from pregnancy concerns to menopausal symptoms, all from the comfort of their own homes.
Technological innovations in fertility and reproductive health have empowered women to take control of their family planning and fertility journey. Techniques such as in-vitro fertilization (IVF), pre-implantation genetic testing, and cryopreservation of eggs have opened up new possibilities and options for women seeking to start or expand their families.
The integration of electronic health records (EHRs) and health information technology has also streamlined the healthcare process. This allows for seamless coordination of care among multiple healthcare providers, ensuring that women receive comprehensive and well-coordinated care.
Mental Health Recognition
Mental health recognition is a significant factor boosting the United States Women's Health Market, as an increasing emphasis on emotional well-being and the destigmatization of mental health issues have reshaped the healthcare landscape. In recent years, there has been a notable shift in societal awareness, advocating for the recognition and prioritization of women's mental health as an integral part of overall well-being.
A key driver in this shift is the recognition of postpartum depression and maternal mental health. Women experiencing postpartum depression and anxiety are now receiving more attention and support, with healthcare providers offering specialized interventions and treatment options to help them navigate the challenges of motherhood. This recognition is vital in ensuring the mental health of both mothers and their infants.
Anxiety and eating disorders, which disproportionately affect women, are also gaining more attention and treatment options. Increased understanding and awareness have led to early diagnosis and intervention, improving the overall quality of life for women who may have otherwise suffered in silence.
The DE stigmatization of mental health issues in society has led to an increased willingness to seek help and access services. Women are more likely to discuss and address their mental health concerns openly with healthcare providers, leading to improved outcomes and quality of care. This shift in attitudes has created a more supportive and inclusive environment for women's mental health, encouraging them to prioritize self-care and seek the assistance they need. Incorporating mental health services into women's healthcare practices is becoming standard, with healthcare providers offering a holistic approach that addresses both physical and emotional well-being. Integrated care models are designed to identify and manage mental health issues alongside physical health concerns, recognizing the intrinsic connection between the two.
Key Market Challenges
Healthcare Disparities and Inequities
Healthcare disparities and inequities continue to be significant challenges hindering the United States Women's Health Market. Despite advancements in medicine and healthcare policy, disparities in access, quality of care, and health outcomes persist, disproportionately affecting women from marginalized communities. These disparities are complex and multifaceted, and addressing them is crucial for achieving comprehensive and equitable women's healthcare. Economic factors play a significant role in healthcare disparities. Women from lower socioeconomic backgrounds may struggle to afford health insurance, preventive care, and necessary treatments. Financial constraints can deter them from seeking early screenings, managing chronic conditions, or accessing specialized healthcare services.
Geographic disparities in healthcare access are a pressing issue in the United States. Rural areas often lack healthcare facilities and specialists, making it challenging for women in these regions to access timely and comprehensive healthcare services. This lack of access can lead to delayed diagnoses and a higher burden of disease.
Barriers to accessing family planning services, including contraception and abortion, can significantly impact women's reproductive health. Restrictions and limitations on these services, combined with limited access in some regions, impede women's ability to make informed choices about their reproductive health and family planning.
Mental health disparities are a growing concern, particularly in the context of women's health. Women from disadvantaged backgrounds may experience higher rates of mental health issues but often face obstacles in accessing mental health services. Stigma, cultural norms, and limited access to mental healthcare professionals contribute to these disparities.
Reproductive Rights and Access
Access to safe and legal abortion services has been a contentious issue in the United States. Restrictive state laws, waiting periods, mandatory counseling, and clinic closures have reduced the availability of abortion services, particularly in rural areas. These barriers can lead to delayed care, increased healthcare costs, and emotional distress for women who seek these services.
While contraception is a fundamental aspect of women's health, limitations on contraceptive access can hinder family planning. Some employers or healthcare institutions may restrict access to certain contraceptive methods based on religious or moral objections. These restrictions can infringe on women's reproductive choices and their ability to manage their reproductive health effectively.
The absence of comprehensive sex education in many regions of the United States leaves individuals, especially young women, ill-informed about their reproductive health and contraceptive options. A lack of education can lead to unplanned pregnancies and increased healthcare needs. Comprehensive sex education is essential in empowering women to make informed choices about their reproductive health.
Access to reproductive healthcare services is not uniform across the country. Rural areas may have limited access to healthcare facilities that offer reproductive services, including prenatal care and family planning. Geographic disparities can result in delayed care, a lack of preventive services, and disparities in reproductive health outcomes.
Family planning clinics, such as Planned Parenthood, have been central to women's healthcare services. However, political and financial challenges have threatened the existence and accessibility of these clinics, which often serve low-income and uninsured women. Reduced funding and clinic closures limit access to contraceptive services, cancer screenings, and reproductive healthcare.
Key Market Trends
Preventive Care and Wellness Promotion
Preventive care and wellness promotion have emerged as powerful drivers boosting the United States Women's Health Market. This key market trend underscores the significance of early detection, health maintenance, and proactive lifestyle choices to enhance women's overall well-being. Preventive care encompasses a range of measures such as regular screenings, vaccinations, and health education, all designed to reduce the incidence and severity of various health conditions.
Routine screenings, including mammograms for breast cancer, Pap smears for cervical cancer, and bone density scans for osteoporosis, are pivotal in the early detection of health issues. By identifying potential problems in their initial stages, women can access timely interventions, increasing the likelihood of successful treatment and improved health outcomes. These screenings are becoming more accessible and are increasingly encouraged by healthcare providers, boosting the market's commitment to proactive health maintenance.
Wellness promotion is another vital aspect of this trend. Lifestyle factors such as nutrition, fitness, and stress management have a profound impact on women's health. Women's health providers are increasingly offering comprehensive wellness programs to address these factors. These programs provide guidance on healthy eating, regular exercise, and stress reduction techniques, empowering women to make positive choices for their overall well-being.
Preventive care and wellness promotion go hand in hand with the reduction of healthcare costs. By preventing or catching health issues early, women can avoid the financial burden associated with treating advanced or chronic conditions. This trend aligns with the principles of value-based healthcare, emphasizing the importance of promoting health and preventing disease rather than solely focusing on treatment.
This market trend encourages women to become proactive about their health, fostering a sense of empowerment and autonomy. By understanding the value of preventive care and adopting a wellness-oriented approach, women can actively participate in managing their health and making informed decisions regarding their well-being.
Reproductive Health Innovations
Reproductive health innovations are playing a pivotal role in boosting the United States Women's Health Market. These advancements encompass a wide range of technologies and practices that are transforming the landscape of women's reproductive health. One of the key areas where innovation has had a profound impact is fertility treatment. Assisted reproductive technologies, such as in vitro fertilization (IVF), have become increasingly effective and accessible, offering hope to couples struggling with infertility. Advanced techniques like pre-implantation genetic testing enable the selection of embryos with a higher chance of successful implantation, reducing the risk of genetic disorders.
Contraception options have also evolved, offering women more choices and control over their reproductive health. Long-acting reversible contraceptives (LARCs), like intrauterine devices (IUDs) and hormonal implants, have gained popularity due to their effectiveness and convenience. This trend towards innovative contraception methods empowers women to make choices that best suit their individual needs and lifestyles.
Reproductive health innovations extend to pregnancy care as well. Prenatal screening and diagnostic tests have improved, providing more accurate information about the health and development of the fetus. Non-invasive prenatal testing (NIPT) has revolutionized the way certain genetic conditions are detected, reducing the need for invasive procedures. Innovations in maternal-fetal monitoring have also enhanced the safety of pregnancy, allowing for early detection and intervention in case of complications.
Technologies like telemedicine have made it easier for women to access reproductive health services, especially in underserved or remote areas. Virtual consultations with healthcare providers and remote monitoring have become essential tools in women's reproductive healthcare, increasing accessibility and convenience.
Segmental Insights
Drug Insights
Based on the Drug, Mirena emerged as the dominant segment in the United States Women's Health Market in 2023. Mirena is an effective, long-lasting contraceptive option that offers convenience and peace of mind to women looking to avoid unwanted pregnancies. Its longevity (it can provide contraception for up to five years) and high efficacy make it a popular choice. Mirena is often prescribed to women with heavy menstrual bleeding or painful periods. It can significantly reduce menstrual flow and alleviate the discomfort associated with severe cramps and heavy bleeding. This makes it an attractive option for women looking to improve their quality of life during menstruation.
Regional Insights
Mid-West emerged as the dominant region in the United States Women's Health Market in 2023, holding the largest market share. The Midwest region has a relatively high concentration of healthcare facilities, making it more accessible for women to seek healthcare services, including those related to women's health. This easy access to providers and healthcare facilities has contributed to the region's dominant position in the market. Midwest healthcare systems often offer a wide range of women's health services, including gynecological care, maternity services, family planning, and women's wellness programs. This comprehensive approach to women's health has attracted patients from both within the region and neighboring areas.
Key Market Players
AbbVie Inc.
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Agile Therapeutics, Inc.
Amgen, Inc.
Apothecus Pharmaceutical Corp.
Eli Lilly and Company
Ferring B.V.
Report Scope:
In this report, the United States Women's Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
United States Women's Health Market, By Drug:
o ACTONEL
o YAZ
o Yasmin
o Yasminelle
o FORTEO
o Minastrin 24 Fe
o Mirena
o NuvaRing
o ORTHO TRI-CY LO
o Premarin
o Prolia
o Reclast/Aclasta
o XGEVA
o Zometa
o Others
United States Women's Health Market, By Application:
o Hormonal Infertility
o Contraceptives
o Postmenopausal Osteoporosis
o Endometriosis & Uterine Fibroids
o Menopause
o Polycystic Ovary Syndrome
United States Women's Health Market, By Distribution Channel:
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
United States Women's Health Market, By Region:
o North-East
o Mid-west
o West
o South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Women's Health Market.
Available Customizations:
United States Women's Health Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. United States Women's Health Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Drug (ACTONEL, YAZ, Yasmin, Yasminelle, FORTEO, Minastrin 24 Fe, Mirena, NuvaRing, ORTHO TRI-CY LO, Premarin, Prolia, Reclast/Aclasta, XGEVA, Zometa, Others)
4.2.2. By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome)
4.2.3. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
4.2.4. By Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Drug
4.3.2. By Application
4.3.3. By Distribution Channel
4.3.4. By Region
5. North-East Women's Health Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug
5.2.2. By Application
5.2.3. By Distribution Channel
6. Mid-west Women's Health Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug
6.2.2. By Application
6.2.3. By Distribution Channel
7. West Women's Health Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug
7.2.2. By Application
7.2.3. By Distribution Channel
8. South Women's Health Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug
8.2.2. By Application
8.2.3. By Distribution Channel
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions
11. United States Women's Health Market: SWOT Analysis
12. Porter's Five Forces Analysis
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Product
13. Competitive Landscape
13.1. AbbVie Inc.
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Services
13.1.4. Financials (In case of listed)
13.1.5. Recent Developments
13.1.6. SWOT Analysis
13.2. Bayer AG
13.3. Merck & Co., Inc.
13.4. Pfizer, Inc.
13.5. Teva Pharmaceutical Industries Ltd.
13.6. Agile Therapeutics, Inc.
13.7. Amgen, Inc.
13.8. Apothecus Pharmaceutical Corp.
13.9. Eli Lilly and Company
13.10. Ferring B.V.
14. Strategic Recommendations
15. About Us & Disclaimer

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE